Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than toxic chemicals – a discovery that could accelerate and improve how medicines ...

Tirzepatide is the active ingredient in Lilly’s popular anti-obesity & diabetes drugs, Mounjaro & Zepbound. Experts say the matter has little relevance for India at present.

WuXi Biologics ('WuXi Bio') (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has won six prestigious awards and two individual ...

Artificial intelligence may be transforming pharmaceutical research, but it will not compress drug development timelines as dramatically as many expect, according to Bill Anderson, chief executive of ...

Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established ...

STGEN Bio, a South Korean biopharmaceutical contract development and manufacturing organization, said Friday it will invest ...

Novo Nordisk — the pharmaceutical giant behind GLP-1 medications like Ozempic and Wegovy — has received a warning letter from the U.S. Food and Drug Administration, for “serious violations” of the age ...

Two popular quantum computing algorithms for problems in chemistry may have very limited use even as quantum hardware ...

Data presented at the 2026 Muscular Dystrophy Association meeting could have readthroughs to companies developing therapies ...

The country’s research spending has seen exponential growth in the past 3 decades, reaching 3.9 trillion yuan ($568.6 billion) in 2025 in current yuan, an 8.1% increase over the previous year, and ...

Midtown-based Dianthus Therapeutics announced a $625 million public offering this week to raise capital for anti-inflammatory drug development. The company, which specializes in treatments for ...